statistiche ricercatore

Continente	#
NA - Nord America	960
AS - Asia	380
EU - Europa	369
SA - Sud America	70
AF - Africa	9
OC - Oceania	3
Continente sconosciuto - Info sul continente non disponibili	2
Totale	1.793

Nazione	#
US - Stati Uniti d'America	947
SG - Singapore	138
CN - Cina	88
GB - Regno Unito	87
IT - Italia	81
BR - Brasile	55
DE - Germania	53
VN - Vietnam	40
HK - Hong Kong	34
SE - Svezia	33
FI - Finlandia	23
TR - Turchia	22
FR - Francia	21
RU - Federazione Russa	20
IN - India	17
UA - Ucraina	13
BG - Bulgaria	8
AE - Emirati Arabi Uniti	6
AR - Argentina	6
BD - Bangladesh	6
KR - Corea	6
CA - Canada	5
MX - Messico	5
NL - Olanda	5
ES - Italia	4
FJ - Figi	3
ID - Indonesia	3
JP - Giappone	3
LT - Lituania	3
MY - Malesia	3
ZA - Sudafrica	3
CH - Svizzera	2
CO - Colombia	2
CZ - Repubblica Ceca	2
EG - Egitto	2
IE - Irlanda	2
IR - Iran	2
KZ - Kazakistan	2
LK - Sri Lanka	2
PH - Filippine	2
PK - Pakistan	2
PT - Portogallo	2
VE - Venezuela	2
AL - Albania	1
AT - Austria	1
BE - Belgio	1
BO - Bolivia	1
CL - Cile	1
CU - Cuba	1
DK - Danimarca	1
DZ - Algeria	1
EC - Ecuador	1
IQ - Iraq	1
IS - Islanda	1
JM - Giamaica	1
JO - Giordania	1
KE - Kenya	1
MU - Mauritius	1
NO - Norvegia	1
PL - Polonia	1
PY - Paraguay	1
QA - Qatar	1
RO - Romania	1
RS - Serbia	1
SA - Arabia Saudita	1
SK - Slovacchia (Repubblica Slovacca)	1
SX - ???statistics.table.value.countryCode.SX???	1
TN - Tunisia	1
TT - Trinidad e Tobago	1
UY - Uruguay	1
XK - ???statistics.table.value.countryCode.XK???	1
Totale	1.793

Nome	#
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study	311
Consensus conference on TIPS management: Techniques, indications, contraindications	293
Hemostatic balance in patients with liver cirrhosis: Report of a consensus conference	262
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis	232
The Italian compassionate use of sofosbuvir in HCV patients waitlisted for liver transplantation: A national real-life experience	214
Portal Hypertension and Ascites: Patient-and Population-centered Clinical Practice Guidelines by the Italian Association for the Study of the Liver (AISF)	187
Prevention of hepatitis C recurrence by bridging sofosbuvir/ribavirin from pre- to post-liver transplant: A real-life strategy	174
The Italian data on SARS-CoV-2 infection in transplanted patients support an organ specific immune response in liver recipients	139
Totale	1.812

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	53	0	0	0	0	0	0	0	0	0	28	20	5
2021/2022	152	5	2	11	5	3	9	6	16	24	12	38	21
2022/2023	176	18	28	17	20	17	23	0	18	20	1	8	6
2023/2024	103	5	8	12	11	8	7	15	12	5	4	1	15
2024/2025	349	11	4	5	26	70	53	15	21	61	18	27	38
2025/2026	504	39	13	24	40	104	66	72	31	61	54	0	0
Totale													1.812